This inventor holds 1 USPTO granted patent. Top assignee: The Population Council, Center for Biomedical Research. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Bogi Andersen: Innovator in Male Contraceptive Research
Introduction
Bogi Andersen is a notable inventor based in La Jolla, California. He has made significant contributions to the field of biomedical research, particularly in the area of male contraceptive agents. His work focuses on the molecular mechanisms underlying male fertility and the potential for developing targeted contraceptive methods.
Latest Patents
Bogi Andersen holds a patent for an isolated DNA molecule encoding the SPRM-1 protein. This patent discloses a POU transcription factor, Sprm-1, along with analogs, DNA molecules encoding the Sprm-1 proteins, and various constructs, vectors, and host cells containing these DNA molecules. The patent also outlines methods for identifying potential male contraceptive agents. One method involves isolating a DNA regulatory region responsive to Sprm-1 and transforming a heterologous cell line with chimeric DNA constructs. This innovative approach allows for the assessment of Sprm-1 inhibitory activity of various compounds and DNA molecules.
Career Highlights
Bogi Andersen is affiliated with The Population Council, Center for Biomedical Research. His research has focused on the development of male contraceptive methods, which could have a profound impact on reproductive health. His work is characterized by a commitment to advancing scientific understanding and practical applications in the field of male fertility.
Collaborations
Bogi Andersen has collaborated with notable colleagues, including Richard V Pearse and Peter N Schlegel. These collaborations have contributed to the advancement of research in male reproductive health and the development of innovative contraceptive solutions.
Conclusion
Bogi Andersen's contributions to the field of male contraceptive research highlight his innovative spirit and dedication to advancing biomedical science. His patent on the SPRM-1 protein and its applications represents a significant step forward in understanding male fertility and developing targeted contraceptive methods.